Pub. Date : 1998 Jun
PMID : 9598563
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | PURPOSE: Sildenafil, an inhibitor of cGMP-specific phosphodiesterase 5 (PDE5), is currently undergoing evaluation as an oral therapy for penile erectile dysfunction. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
2 | Compared with zaprinast, an early PDE5 inhibitor, sildenafil was approximately 240-fold more potent, inhibiting PDE5 from HCC with a geometric mean IC50 of 3.5 nM. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
3 | Compared with zaprinast, an early PDE5 inhibitor, sildenafil was approximately 240-fold more potent, inhibiting PDE5 from HCC with a geometric mean IC50 of 3.5 nM. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
4 | Sildenafil is a potent inhibitor of PDE5 from HCC, with high selectivity for PDE5 relative to other PDE isozymes. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
5 | Sildenafil is a potent inhibitor of PDE5 from HCC, with high selectivity for PDE5 relative to other PDE isozymes. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |